Pre-IND Preparations for a Precision Antimicrobial Targeted against the Bacterium Clostridium Difficile
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Locus Biosciences
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Paul Garofolo
Fiscal Year
2017
Region
Research Triangle
Project Description:
Locus Biosciences is developing a suite of narrow-spectrum antimicrobials for infectious diseases including drug-resistant bacteria using proprietary CRISPR technology. SGL funds will be used to conduct pre-IND-enabling activities for their C. diff-targeting therapeutic, LBx-CD01.